Catalent
CTLT
#1499
Rank
C$16.68 B
Marketcap
$91.92
Share price
0.00%
Change (1 day)
40.13%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -$1.73

According to Catalent's latest financial reports the company's current EPS (TTM) is -$1.87. In 2022 the company made an earnings per share (EPS) of $3.29 a decrease over its 2021 EPS that were of $4.73.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.73-152.61%
2022$3.29-30.58%
2021$4.7379.67%
2020$2.64114.12%
2019$1.23-15%
2018$1.4575.44%
2017$0.83-22.97%
2016$1.07-59.56%
2015$2.65282.05%
2014$0.69-378.2%
2013-$0.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.14-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.09-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.04 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$9.25-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA